University of Queensland researchers announced a national Phase 2 trial of the experimental treatment NUN-004. The study plans to enrol 75 people with motor neurone disease. The treatment is designed to target a pathway involved in nerve-cell damage. Earlier testing suggested the approach was tolerable, but involved small numbers. Researchers have not yet shown that it stops or reverses the disease in a larger population.